We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AACC 2023 Celebrates 75 Years of Innovation and Future of Laboratory Medicine

By LabMedica International staff writers
Posted on 18 Jul 2023
Print article
Image: The 2023 AACC Clinical Lab Expo is the premier global laboratory medicine exposition (Photo courtesy of AACC)
Image: The 2023 AACC Clinical Lab Expo is the premier global laboratory medicine exposition (Photo courtesy of AACC)

The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo is showcasing breakthrough innovations shaping the future of clinical testing and patient care. The world's largest exhibition for in vitro diagnostics is hosted every year by the American Association for Clinical Chemistry (Washington, DC, USA).  AACC 2023 is being held from July 23-27 at the Anaheim Convention Center in California, where laboratory medicine experts are presenting cutting-edge research and technology.

Attendees can benefit from a stunning lineup of expert speakers and scientific sessions, as well as view a vast array of emerging technologies and products at the premier global laboratory medicine exposition. The AACC Clinical Lab Expo offers attendees the opportunity to browse more than 900 exhibitors across over 200 product categories in person for solutions to their lab-related needs. They can connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other fields of breaking science in laboratory medicine. Attendees can also hear vital research and learn about important changes in the field. With over 250 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions, they can design an educational experience that fulfills their need to keep ahead of the changes in their field.

At AACC 2023, attendees can visit the electronic billboard outside the Expo Hall entrance to learn about innovative new products and services. They have the opportunity to interact with the product showcase to obtain detailed product and service information. Attendees can also learn about the latest diagnostic technologies and services in 20-minute lecture series presentations at the theater conveniently located in the exhibit hall without the need to leave the action of the Expo. At the exhibit hall theaters, attendees can learn about new diagnostic breakthroughs and significant developments in laboratory medicine. Industry workshops are also being offered in nearby hotels. Posters of accepted abstracts are on display in the Poster Hall on the Expo Show floor for both scientific conference and expo hall attendees to visit.

This year, the AACC Clinical Lab Expo is providing additional opportunities to network with colleagues and make new connections. The Clinical Lab Expo Happy Hour is back this year where attendees can mix and mingle and will receive one complimentary drink ticket. They can also enjoy an afternoon break on the expo floor with light refreshments to recharge and connect with fellow attendees and exhibitors. This year, AACC is once again hosting its popular annual Laboratory Feud – a special game show-style event. The two teams, Faculty vs. Fellows, will compete by continuing the celebration of AACC’s 75th anniversary with coverage in different areas of laboratory medicine including history, nutrition, pre-analytical errors, testing methods, immunology, point-of-care testing, TDM and toxicology, among others. To remind everyone of all the innovations the field has seen in the past 75 years, the feud will end with a fast money/lightning round that focuses exclusively on AACC history trivia.

Related Links:
American Association for Clinical Chemistry

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.